Akili made headlines in 2020 when it received Food and Drug Administration clearance for EndeavorRx, a video game designed to treat pediatric ADHD. Akili went public in 2022 in a deal that valued ...

Akili Interactive, the company behind a video game-like prescription digital therapeutic for children with ADHD, reported its first full-year earnings since going public last year. The company ...

That slimdown was sparked by Akili’s plummeting stock price and the sizable gap between its revenues and operating expenses—which totaled $323,000 and $90.6 million, respectively, for all of 2022.

Akili stock surges ~40% after video game EndeavorRx shows benefit in ADHD adults May 03, 2023 9:43 AM ET Akili, Inc. (AKLI) Stock By: Ravikash Bakolia, SA News Editor Vertigo3d ...

Akili, the company behind video game-like prescription and over-the-counter digital therapeutics for individuals with ADHD, has signed a definitive merger agreement with mental health and fitness ...

Akili Interactive, which in 2020 made waves by receiving Food and Drug Administration clearance for its video game that improves symptoms of ADHD in children, on Wednesday announced it would ...